» Articles » PMID: 26236989

Snail1-induced Partial Epithelial-to-mesenchymal Transition Drives Renal Fibrosis in Mice and Can Be Targeted to Reverse Established Disease

Overview
Journal Nat Med
Date 2015 Aug 4
PMID 26236989
Citations 382
Authors
Affiliations
Soon will be listed here.
Abstract

Progressive kidney fibrosis contributes greatly to end-stage renal failure, and no specific treatment is available to preserve organ function. During renal fibrosis, myofibroblasts accumulate in the interstitium of the kidney, leading to massive deposition of extracellular matrix and organ dysfunction. The origin of myofibroblasts is manifold, but the contribution of an epithelial-to-mesenchymal transition (EMT) undergone by renal epithelial cells during kidney fibrosis is still debated. We show that the reactivation of Snai1 (encoding snail family zinc finger 1, known as Snail1) in mouse renal epithelial cells is required for the development of fibrosis in the kidney. Damage-mediated Snail1 reactivation induces a partial EMT in tubular epithelial cells that, without directly contributing to the myofibroblast population, relays signals to the interstitium to promote myofibroblast differentiation and fibrogenesis and to sustain inflammation. We also show that Snail1-induced fibrosis can be reversed in vivo and that obstructive nephropathy can be therapeutically ameliorated in mice by targeting Snail1 expression. These results reconcile conflicting data on the role of the EMT in renal fibrosis and provide avenues for the design of novel anti-fibrotic therapies.

Citing Articles

Dual activation of GCGR/GLP1R signaling ameliorates intestinal fibrosis metabolic regulation of histone H3K9 lactylation in epithelial cells.

Liu H, Hong Y, Chen H, Wang X, Dong J, Li X Acta Pharm Sin B. 2025; 15(1):278-295.

PMID: 40041889 PMC: 11873616. DOI: 10.1016/j.apsb.2024.11.017.


Cross-talk of renal cells through WNT signal transduction in the development of fibrotic kidneys.

Chen Y, Xue C Front Cell Dev Biol. 2025; 12:1517181.

PMID: 40012992 PMC: 11860889. DOI: 10.3389/fcell.2024.1517181.


Metabolite pathway alterations identified by magnetic resonance metabolomics in a proximal tubular epithelial cell line treated with TGF-β1.

Humphries T, Lee S, Urquhart A, Vesey D, Micallef A, Winterford C Physiol Rep. 2025; 13(4):e70249.

PMID: 39957082 PMC: 11830627. DOI: 10.14814/phy2.70249.


Yiqi Juanshen decoction alleviates renal interstitial fibrosis by targeting the LOXL2/PI3K/AKT pathway to suppress EMT and inflammation.

Tan K, Deng J, Liu Y, Zhang Y, Xiong Y, Yuan S Sci Rep. 2025; 15(1):4248.

PMID: 39905060 PMC: 11794949. DOI: 10.1038/s41598-025-86622-7.


UHRF1 promotes epithelial-mesenchymal transition mediating renal fibrosis by activating the TGF-β/SMAD signaling pathway.

Yang L, Si P, Kuerban T, Guo L, Zhan S, Zuhaer Y Sci Rep. 2025; 15(1):3346.

PMID: 39870702 PMC: 11772867. DOI: 10.1038/s41598-025-86496-9.


References
1.
Esteban V, Lorenzo O, Ruperez M, Suzuki Y, Mezzano S, Blanco J . Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol. 2004; 15(6):1514-29. DOI: 10.1097/01.asn.0000130564.75008.f5. View

2.
Liu Y . Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 2006; 69(2):213-7. DOI: 10.1038/sj.ki.5000054. View

3.
Biswas S, Mantovani A . Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010; 11(10):889-96. DOI: 10.1038/ni.1937. View

4.
LeBleu V, Taduri G, OConnell J, Teng Y, Cooke V, Woda C . Origin and function of myofibroblasts in kidney fibrosis. Nat Med. 2013; 19(8):1047-53. PMC: 4067127. DOI: 10.1038/nm.3218. View

5.
Kriz W, Kaissling B, Le Hir M . Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?. J Clin Invest. 2011; 121(2):468-74. PMC: 3026733. DOI: 10.1172/jci44595. View